eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications

Eclampsia

Author: Michael G Ross, MD, MPH, Professor of Obstetrics and Gynecology, David Geffen School of Medicine, University of California at Los Angeles; Professor, Department of Community Health Sciences, University of California at Los Angeles School of Public Health; Chair, Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center
Contributor Information and Disclosures

Updated: Apr 1, 2009

Introduction

Background

Eclampsia is commonly defined as new onset of grand mal seizure activity and/or unexplained coma during pregnancy or postpartum in a woman with signs or symptoms of preeclampsia. Nonetheless, eclampsia in the absence of hypertension with proteinuria has been demonstrated to occur in 38% of cases reported in the United Kingdom.¹ Similarly, hypertension was absent in 16% of cases reviewed in the United States.²

Most cases of eclampsia present in the third trimester of pregnancy, with about 80% of eclamptic seizures occurring intrapartum or within the first 48 hours following delivery. Rare cases have been reported prior to 20 weeks' gestation or as late as 23 days’ postpartum. Other than early detection of preeclampsia, no reliable test or symptom complex predicts the development of eclampsia. In developed countries, most of recent reported cases have been classified as unpreventable.

Pathophysiology

Many investigators have proposed factors relating to genetics, immunology, endocrinology, nutrition, and infection as possible etiologies leading to the development of preeclampsia/eclampsia. Despite extensive research, no definitive cause for preeclampsia has been identified (see eMedicine article Preeclampsia). The pathogenesis of eclamptic seizures may include mechanisms of cerebral vasoconstriction, hypertensive encephalopathy, cerebral edema, hemorrhage, and infarction. Whether these findings are causes or results of seizure activity is unclear.

Preeclampsia/eclampsia produces multiple systemic derangements that can involve a diversity of organ systems including hematologic, hepatic, renal, and cardiovascular systems as well as the central nervous system. The severity of these derangements often correlates with maternal medical (eg, pre-existing renal or vascular pathology) or obstetric factors (eg, multifetal gestations or molar pregnancy).

Systemic derangements associated with eclampsia can include the following:

• Cardiovascular 
  • Generalized vasospasm
  • Increased peripheral vascular resistance
  • Increased left ventricular stroke work index
  • Decreased central venous pressure
  • Decreased pulmonary wedge pressure
• Hematologic
  • Decreased plasma volume
  • Increased blood viscosity
  • Hemoconcentration
  • Coagulopathy
• Renal
  • Decreased glomerular filtration rate
  • Decreased renal plasma flow
  • Decreased uric acid clearance
• Hepatic
  • Periportal necrosis
  • Hepatocellular damage
  • Sub capsular hematoma
• Central nervous system
  • Cerebral over perfusion due to loss of autoregulation
  • Cerebral edema
  • Cerebral hemorrhage

Frequency

United States

Primigravid and multifetal pregnancies as well as pregnancies in women without access to prenatal care have been identified as having an increased frequency of eclampsia. In the United States, some studies have identified an increased frequency in African Americans and in women with pre-existing cardiovascular or renal complications.³

International

The incidence of eclampsia varies between and within countries. Overall, the rate of eclampsia is higher in developing countries. The highest rate was reported in Columbia (8.1/1000) and the lowest rate was reported in the United Kingdom (0.49/1000 deliveries).⁴ In the developed world, the reported incidence of eclampsia ranges from 1 in 1,000 to 1 in 3,448 pregnancies.^1,3

Mortality/Morbidity

Eclampsia accounts for approximately 50,000 maternal deaths worldwide annually. In developed countries, the maternal death rate has been reported as 0-1.8%. A CDC study found an overall preeclampsia-eclampsia case-fatality rate of 6.4 per 10,000 cases at delivery with a rate twice as high for black women compared with white women. This same study found an increased risk of death among women older than 30 years and those with no prenatal care. The highest risk for maternal death was found in pregnancies at 28 weeks’ gestation or less. The maternal mortality rate is as high as 14% in developing countries.⁵ The perinatal mortality rate from eclampsia in recent reviews in the United States and Great Briton ranges from 5.6-11.8%.^1,6

Maternal complications of eclampsia may include permanent CNS damage from recurrent seizures or intracranial bleeds, disseminated intravascular coagulopathy, renal insufficiency, pulmonary edema, and cardiopulmonary arrest.

Race

Ethnic or racial predilections are unclear. A higher incidence of this condition may exist in African Americans.

Sex

Only females are affected.

Age

Recent reviews confirm both an increase in frequency of preeclampsia/eclampsia and severity of complications (including an increased mortality) risk in older gravidas, especially women aged 40 years or older. Previously reported increased risk in younger women has not been found in recent reviews.

Clinical

History

• Eclampsia is defined by tonic-clonic seizure activity (focal or generalized) or unexplained coma.
• Frequency of signs or symptoms prior to seizure include the following:
  • Headache (83%)
  • Hyperactive reflexes (80%)
  • Marked proteinuria (52%)
  • Generalized edema (49%)
  • Visual disturbances (44%)
  • Right upper quadrant pain or epigastric pain (19%)
• Absence of signs or symptoms prior to seizure include the following:
  • Lack of edema (39%)
  • Absence of proteinuria (21%)
  • Normal reflexes (20%)
• Relation to delivery
  • More than 70% occur prior to delivery.
  • 25% occur before labor (antepartum).
  • 50% occur during labor (intrapartum).
  • 25% occur after delivery (postpartum).
• Patients with severe preeclampsia are at greater risk to develop seizures.
• 25% of patients have symptoms consistent with mild preeclampsia prior to the seizures.

Physical

• Eclamptic seizure
  • One or more seizures may occur.
  • Seizures generally last 60-75 seconds.
  • The face initially may become distorted with protrusion of the eyes.
  • Foaming at the mouth may occur.
  • Respiration ceases for the duration of the seizure.
• The seizure may be divided into 2 phases:
  • Phase 1 lasts 15-20 seconds and begins with facial twitching. The body becomes rigid, leading to generalized muscular contractions.
  • Phase 2 lasts about 60 seconds. It starts in the jaw, moves to the muscles of the face and eyelids, and then spreads throughout the body. The muscles begin alternating between contracting and relaxing in rapid sequence.
• A coma or a period of unconsciousness follows phase 2.
  • Unconsciousness lasts for a variable period.
  • Following the coma phase, the patient may regain some consciousness.
  • The patient may become combative and very agitated.
  • The patient has no recollection of the seizure.
• A period of hyperventilation occurs after the tonic-clonic seizure. This compensates for the respiratory and lactic acidosis that develops during the apneic phase.
• Seizure-induced complications may include tongue biting, head trauma, broken bones, or aspiration.

Causes

The cause of the seizures is not clear, although several processes have been implicated in their development.

• Areas of cerebral vasospasm may be severe enough to cause focal ischemia, which may in turn lead to seizures.
• Pathologic alterations in cerebral blood flow and tissue edema induced by vasospasm may result in headaches, visual disturbances, and hypertensive encephalopathy, resulting in a seizure.

• Search for CME/CE on This Topic »

• Preeclampsia and Eclampsia (Neurology)
• Pregnancy, Eclampsia (Emergency Medicine)
• Hypertension (Ophthalmology)
• Small Left Colon Syndrome (Pediatrics: Surgery)

• Risk of Pre-Eclampsia Recurrence May Be Overestimated
• Preeclampsia Linked to Hypothyroidism
• Labor Induction at 37 Weeks Recommended for Women With Mild Hypertensive Disorders

• Risk of Pre-eclampsia in First and Subsequent Pregnancies: Prospective Cohort Study
• Induction Of Labour Versus Expectant Monitoring For Gestational Hypertension or Mild Pre-Eclampsia After 36 Weeks' Gestation (HYPITAT). F1000 Ranking "Exceptional" and "Changes Practice"
• Cardiovascular Sequelae of Preeclampsia/Eclampsia: A Systematic Review and Meta-Analyses